Bruce G. Allen Investments LLC Has $33,000 Stock Holdings in Humana Inc. (NYSE:HUM)

Bruce G. Allen Investments LLC decreased its stake in shares of Humana Inc. (NYSE:HUM) by 26.0% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 131 shares of the insurance provider’s stock after selling 46 shares during the quarter. Bruce G. Allen Investments LLC’s holdings in Humana were worth $33,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently made changes to their positions in the stock. Atlas Brown Inc. raised its position in Humana by 0.6% during the fourth quarter. Atlas Brown Inc. now owns 6,352 shares of the insurance provider’s stock worth $1,611,000 after acquiring an additional 38 shares in the last quarter. Moors & Cabot Inc. lifted its stake in Humana by 2.5% in the 3rd quarter. Moors & Cabot Inc. now owns 1,639 shares of the insurance provider’s stock valued at $519,000 after purchasing an additional 40 shares during the last quarter. OLD National Bancorp IN grew its holdings in Humana by 1.8% during the third quarter. OLD National Bancorp IN now owns 2,613 shares of the insurance provider’s stock worth $828,000 after purchasing an additional 45 shares during the period. Your Advocates Ltd. LLP increased its position in Humana by 81.8% during the third quarter. Your Advocates Ltd. LLP now owns 100 shares of the insurance provider’s stock worth $32,000 after buying an additional 45 shares during the last quarter. Finally, Brooklyn Investment Group lifted its position in shares of Humana by 6.7% in the third quarter. Brooklyn Investment Group now owns 736 shares of the insurance provider’s stock valued at $233,000 after buying an additional 46 shares during the last quarter. Institutional investors own 92.38% of the company’s stock.

Insider Buying and Selling

In other Humana news, insider Timothy S. Huval sold 3,703 shares of the firm’s stock in a transaction on Tuesday, December 31st. The shares were sold at an average price of $256.26, for a total value of $948,930.78. Following the completion of the sale, the insider now directly owns 8,181 shares in the company, valued at approximately $2,096,463.06. This trade represents a 31.16 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 0.32% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

A number of research analysts recently weighed in on the company. Deutsche Bank Aktiengesellschaft decreased their target price on Humana from $349.00 to $250.00 and set a “hold” rating on the stock in a report on Thursday, October 3rd. Royal Bank of Canada cut their target price on shares of Humana from $400.00 to $265.00 and set an “outperform” rating for the company in a research note on Tuesday, October 8th. Morgan Stanley upped their price target on shares of Humana from $288.00 to $301.00 and gave the company an “equal weight” rating in a research note on Tuesday, December 17th. Leerink Partnrs downgraded shares of Humana from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, October 2nd. Finally, Bank of America raised Humana from an “underperform” rating to a “neutral” rating and upped their target price for the company from $247.00 to $308.00 in a research report on Wednesday, November 6th. Twenty investment analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. According to MarketBeat.com, Humana currently has an average rating of “Hold” and a consensus price target of $302.00.

Humana Price Performance

Shares of NYSE:HUM traded up $1.63 during trading on Friday, hitting $269.76. 1,146,763 shares of the company were exchanged, compared to its average volume of 1,146,409. The company has a market capitalization of $32.48 billion, a P/E ratio of 23.89, a price-to-earnings-growth ratio of 2.12 and a beta of 0.55. Humana Inc. has a 1-year low of $213.31 and a 1-year high of $459.76. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.67. The business’s 50 day moving average is $273.07 and its 200-day moving average is $311.56.

Humana (NYSE:HUM) last announced its quarterly earnings results on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.48 by $0.68. The firm had revenue of $29.30 billion during the quarter, compared to analysts’ expectations of $28.66 billion. Humana had a net margin of 1.18% and a return on equity of 13.20%. Equities analysts forecast that Humana Inc. will post 16.14 earnings per share for the current year.

Humana Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Stockholders of record on Tuesday, December 31st will be given a dividend of $0.885 per share. The ex-dividend date of this dividend is Tuesday, December 31st. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.31%. Humana’s dividend payout ratio (DPR) is 31.36%.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.